• LAST PRICE
    0.9200
  • TODAY'S CHANGE (%)
    Trending Down-0.0100 (-1.0753%)
  • Bid / Lots
    0.9100/ 5
  • Ask / Lots
    1.1000/ 1
  • Open / Previous Close
    0.9300 / 0.9300
  • Day Range
    Low 0.9200
    High 0.9300
  • 52 Week Range
    Low 0.9000
    High 3.0000
  • Volume
    3,625
    average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

  • Oct 28, 2024

  • Oct 22, 2024

      Show headlines and story abstract
    • 4:45PM ET on Tuesday Oct 22, 2024 by Dow Jones
      Companies Mentioned: CNVI

      Conavi Medical Corp. Engages ICP Securities Inc. for Automated Market Making Services

      TORONTO, Oct. 22, 2024 (GLOBE NEWSWIRE) -- CONAVI MEDICAL CORP. (TSXV: CNVI) ("CONAVI MEDICAL" or the "Company"), a commercial stage company focused on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures, is pleased to announce that it has engaged the services of ICP Securities Inc. ("ICP") to provide automated market making services, including use of its proprietary algorithm, ICP Premium(TM), in compliance with the policies and guidelines of the TSX Venture Exchange ("TSXV") and other applicable legislation, and subject to the receipt of approval by the TSXV. ICP will be paid a monthly fee of C$7,500, plus applicable taxes. The agreement between the Company and ICP was signed with a start date of October 22, 2024, and is for four (4) months (the "Initial Term") and shall be automatically renewed for subsequent one (1) month terms (each month called an "Additional Term") unless either party provides at least thirty (30) days written notice prior to the end of the Initial Term or an Additional Term, as applicable. There are no performance factors contained in the agreement and no stock options or other equity compensation in connection with the engagement. ICP has informed the Company that it does not currently own any securities of the Company; however, ICP and its clients may acquire an interest in the securities of the Company in the future.

Peers Headlines